0001104659-23-068343.txt : 20230606 0001104659-23-068343.hdr.sgml : 20230606 20230606080657 ACCESSION NUMBER: 0001104659-23-068343 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230602 FILED AS OF DATE: 20230606 DATE AS OF CHANGE: 20230606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D CENTRAL INDEX KEY: 0001076979 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 23994928 MAIL ADDRESS: STREET 1: 18 CHERRYVILLE RD CITY: FLEMINGTON STATE: NJ ZIP: 08822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Astria Therapeutics, Inc. CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090127 4 1 tm2317752-9_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-02 0 0001454789 Astria Therapeutics, Inc. ATXS 0001076979 KISHBAUCH MICHAEL D C/O ASTRIA THERAPEUTICS, INC. 75 STATE STREET, SUITE 1400 BOSTON MA 02109 1 0 0 0 0 Stock Option (Right to Buy) 11.35 2023-06-02 4 A 0 14100 0 A 2033-06-01 Common Stock 14100 14100 D This option was granted on June 2, 2023 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service. /s/ Ben Harshbarger, as attorney-in-fact for Michael Kishbauch 2023-06-06